Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 8Unknown 4Withdrawn 2Terminated 2Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 1

Interventions

Paclitaxel 5Radiotherapy 3Fluorouracil 3Carboplatin 3nimotuzumab 2Taxes 2S 1 (combination) 2Radiation 2Oxaliplatin 2Nivolumab 2Ferrosoferric Oxide 2Drug Therapy 2Cisplatin 2Cetuximab 2pembrolizumab 1entinostat 1atezolizumab 1apatinib 1Watchful Waiting 1Trastuzumab 1TH 302 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Proton Therapy 1Polymerase Chain Reaction 1Observation 1Nimodipine 1Magnetic Resonance Spectroscopy 1Lubricant Eye Drops 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Esophageal Neoplasms × S 1 (combination) × Clear all
NCT02716688 2023-09-22

S-1 and Radiotherapy for Elderly Esophageal Cancer Patients

Zhejiang Provincial People's Hospital

Phase 2 Withdrawn
Gastrointestinal

Esophageal Neoplasms

NCT03991104 2023-09-21

SOX-based CRT for Esophageal Cancer.

Zhejiang Provincial People's Hospital

Phase 1/2 Withdrawn
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡